Zurex Pharma Receives $6,200,000 Series A Funding Round

  • Feed Type
  • Date
    5/22/2012
  • Company Name
    Zurex Pharma
  • Mailing Address
    2113 Eagle Drive Middleton, WI 53562
  • Company Description
    Zurex Pharma, Inc. is a specialty pharma and medical technology company with a novel antimicrobial technology platform. Our company’s mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections.
  • Website
    http://www.zurex-pharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,200,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Zurex will use the capital to develop and commercialize a portfolio of innovative antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections.
  • M&A Terms
  • Venture Investor
    Baird Capital
  • Venture Investor
    Baird Capital
  • Venture Investor
    Wisconsin Investment Partners
  • Venture Investor
    Peak Ridge Capital